Completed NA INTERVENTIONAL 1-arm NCT05825599

PMCF Study to Evaluate Performance and Safety of HPMC-based Eyedrops Used to Relieve Dry Eye Symptoms

An Interventional, Non-comparative, Single-center Post Marketing Clinical Follow-up (PMCF) Study to Evaluate Performance and Safety of Hydroxypropyl Methylcellulose (HPMC)-Based Eyedrops Used to Relieve Dry Eye Symptoms

Sponsor: C.O.C. Farmaceutici S.r.l.

Conditions Dry Eye Dry Eye Disease Kerato Conjunctivitis Sicca

Interventions Hydroxypropyl methylcellulose eye drops

Updated 3 times since 2023 Last updated: Apr 11, 2023 Started: Sep 6, 2022 Primary completion: Jan 30, 2023 Completion: Jan 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Dry Eye and Dry Eye Disease, this trial is completed. The trial is conducted by C.O.C. Farmaceutici S.r.l. and has accumulated 3 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2023 — Jul 2024 [monthly]

Completed NA

First recorded

Sep 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

C.O.C. Farmaceutici S.r.l.

Data source: C.O.C. Farmaceutici S.r.l.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Catanzaro, Italy